U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07832461) titled 'ANCILLARY STUDY No. 3 NS-PARK-OMICS' on Sept. 16.
Brief Summary: The goal of this clinical study is to identify biomarkers associated with Parkinson's disease (PD) progression in PD patients, participants at-risk of developing PD (e.g., a person who does not have the disease but carrying a mutation known to be related to the disease or a person with a prodromal form as iRBD for example), as well as healthy volunteers. The working hypothesis of this study is that patients with Parkinson's disease can be stratified into etiological subgroups through the integration of omics data. Combining molecular signatures with longitudinal clini...